Buy Ovid Therapeutics Stock | OVID Stock Price & Latest News | Public.com
OVID

Ovid Therapeutics

$0.00 (0.00%)Today
    View Ovid Therapeutics (OVID) stock trends here

    About OVID

    Ovid Therapeutics, Inc. focuses on developing medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY. The full company name is Ovid Therapeutics, Inc....

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    1.22
    0.68
    0.13
    -0.41
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    $1.22

    Actual EPS
    Q1 2021

    Stats

    Market Cap$255M
    Volume4,23M
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$9.40
    1 Year Low$1.80
    Open$4.00
    High$4.01
    Low$3.55

    Buy any stock with any amount of money.

    Download the App
    Download the app